Novo Nordisk CEO to step down, timeline for successor unknown

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down, the company announced Friday morning. Novo has begun a search for Jørgensen’s successor, and Jørgensen will continue as CEO until one is found. No timeline has ...

Related Posts

Some generics, biosimilar drugmakers say they can withs...

May 13, 2025  0

Dutch biotech Azafaros gets $146M for Phase 3 trials in...

May 13, 2025  0

PhRMA warns against tariffs as industry probe closes fo...

May 7, 2025  0

Comments

Name

Email

Comment

Post Comment